Details of the Drug-Related molecule(s) Expression Atlas
General Information of Drug (ID: DM27HMT)
Drug Name | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
4894-26-2; 4,9-dihydro-3H-Pyrido[3,4-b]indole; 4,9-dihydro-3H-beta-carboline; 3H-Pyrido(3,4-b)indole, 4,9-dihydro-; 3,4-dihydro-beta-carboline; CHEMBL266221; 4,9-Dihydro-3H-pyrido(3,4-b)indole; 3H-Pyrido[3,4-b]indole, 4,9-dihydro-; AC1L3RVU; 3,4-dihydrobeta-carboline; SCHEMBL678673; CTK7D1379; DTXSID20197643; ZINC332024; BDBM50136506; SBB062953; FCH841675; AKOS006272808; ACM4894262; 3H,4H,9H-PYRIDO[3,4-B]INDOLE; TX-010240; FT-0698471
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecule(s) Related to This Drug
Drug Therapeutic Target (DTT) |
|
|||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs
|
|||||||||||||||||||||||||||||||||
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs | |||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue
The Studied Disease | Discovery agent | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue | ||||||||||||||||||||||||||||||